Philogen Expands Treasury Share Buyback, Nears 0.87% of Share Capital Held

Philogen SpA ( (IT:PHIL) ) has shared an update.

Philogen has provided an update on its ongoing treasury share buyback program, detailing that it repurchased 3,005 shares on Euronext Milan between 2 and 6 March 2026 at an average price of €20.9924, for a total outlay of €63,082.27. The purchases represent about 0.0074% of its share capital and form part of a broader shareholder-authorized program initiated in 2025.

Since the launch of the program, the biotech group has bought back 58,881 shares for roughly €1.3 million, bringing its total treasury holdings to 352,831 shares, or 0.8688% of its share capital as of 6 March 2026. The incremental accumulation of treasury stock may signal management’s confidence in the company’s valuation and provides additional flexibility for future capital management initiatives, potentially affecting shareholder structure and liquidity over time.

The most recent analyst rating on (IT:PHIL) stock is a Buy with a EUR24.50 price target. To see the full list of analyst forecasts on Philogen SpA stock, see the IT:PHIL Stock Forecast page.

More about Philogen SpA

Philogen is an Italian-Swiss biotechnology group focused on discovering and developing targeted anti-cancer drugs for diseases with high mortality rates. The company uses proprietary tumor-targeting technologies, including antibody phage display and DNA-encoded chemical libraries, to deliver potent therapeutic agents directly to tumors while sparing healthy tissues, with applications primarily in oncology and potentially in chronic inflammatory diseases.

Its core strategy, known as vascular targeting, centers on antibody-based ligands that recognize antigens expressed in blood vessels associated with tumors but not in normal vasculature. Supported by extensive know-how in targeted drug development, manufacturing and a broad patent portfolio, Philogen aims to bring innovative therapies to market where current medical options remain inadequate.

YTD Price Performance: -7.73%

Average Trading Volume: 20,532

Technical Sentiment Signal: Buy

Current Market Cap: €628.7M

See more insights into PHIL stock on TipRanks’ Stock Analysis page.